188 related articles for article (PubMed ID: 7639204)
1. Diagnosing comorbidity in substance abusers: a comparison of the test-retest reliability of two interviews.
Ross HE; Swinson R; Doumani S; Larkin EJ
Am J Drug Alcohol Abuse; 1995 May; 21(2):167-85. PubMed ID: 7639204
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
Ross HE; Swinson R; Larkin EJ; Doumani S
J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic structured interviews in child and adolescent's psychiatry].
Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview].
Massoubre C; Bonnefond H; Grosselin A; Nelva A; Pellet J; Lang F
Encephale; 2009 Dec; 35(6):544-53. PubMed ID: 20004285
[TBL] [Abstract][Full Text] [Related]
7. Twelve month test-retest reliability of a Japanese version of the Structured Clinical Interview for DSM-IV Personality Disorders.
Osone A; Takahashi S
Psychiatry Clin Neurosci; 2003 Oct; 57(5):532-8. PubMed ID: 12950709
[TBL] [Abstract][Full Text] [Related]
8. Personality disorders in substance abusers: relation to substance use.
Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
[TBL] [Abstract][Full Text] [Related]
10. Clinical validity and intrarater and test-retest reliability of the Structured Clinical Interview for DSM-5 - Clinician Version (SCID-5-CV).
Osório FL; Loureiro SR; Hallak JEC; Machado-de-Sousa JP; Ushirohira JM; Baes CVW; Apolinario TD; Donadon MF; Bolsoni LM; Guimarães T; Fracon VS; Silva-Rodrigues APC; Pizeta FA; Souza RM; Sanches RF; Dos Santos RG; Martin-Santos R; Crippa JAS
Psychiatry Clin Neurosci; 2019 Dec; 73(12):754-760. PubMed ID: 31490607
[TBL] [Abstract][Full Text] [Related]
11. Twelve-month test-retest reliability of the structured clinical interview for DSM-III-R personality disorders in cocaine-dependent patients.
Weiss RD; Najavits LM; Muenz LR; Hufford C
Compr Psychiatry; 1995; 36(5):384-9. PubMed ID: 7497713
[TBL] [Abstract][Full Text] [Related]
12. Validity of the SCID in substance abuse patients.
Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two interview schedules. The Schedule for Affective Disorders and Schizophrenia-Lifetime and the National Institute for Mental Health Diagnostic Interview Schedule.
Hesselbrock V; Stabenau J; Hesselbrock M; Mirkin P; Meyer R
Arch Gen Psychiatry; 1982 Jun; 39(6):674-7. PubMed ID: 7092500
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of alcohol and drug diagnoses.
Berney A; Preisig M; Matthey ML; Ferrero F; Fenton BT
Drug Alcohol Depend; 2002 Jan; 65(2):149-58. PubMed ID: 11772476
[TBL] [Abstract][Full Text] [Related]
15. Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population.
Hasin DS; Shmulewitz D; Stohl M; Greenstein E; Aivadyan C; Morita K; Saha T; Aharonovich E; Jung J; Zhang H; Nunes EV; Grant BF
Drug Alcohol Depend; 2015 Jul; 152():246-56. PubMed ID: 25939727
[TBL] [Abstract][Full Text] [Related]
16. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I).
Skre I; Onstad S; Torgersen S; Kringlen E
Acta Psychiatr Scand; 1991 Aug; 84(2):167-73. PubMed ID: 1950612
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity in a clinical sample of substance abusers.
Skinstad AH; Swain A
Am J Drug Alcohol Abuse; 2001 Feb; 27(1):45-64. PubMed ID: 11373036
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing antisocial personality disorder among substance abusers: the scid versus the MCMI-II.
Messina N; Wish E; Hoffman J; Nemes S
Am J Drug Alcohol Abuse; 2001 Nov; 27(4):699-717. PubMed ID: 11727884
[TBL] [Abstract][Full Text] [Related]
19. Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID).
Shankman SA; Funkhouser CJ; Klein DN; Davila J; Lerner D; Hee D
Int J Methods Psychiatr Res; 2018 Mar; 27(1):. PubMed ID: 29034525
[TBL] [Abstract][Full Text] [Related]
20. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
